EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Sanctuary Within: Development of CD20+ CNS Lymphoma Despite Peripheral B‐Cell Depletion by Rituximab in a Multiple Sclerosis Patient

Mohammad Hossein Harirchian iD, Seyed Ehsan Mohammadianinejad iD, Asghar Bayati iD, Vahid Soleimani iD, Zahra Sarvestani iD, Maryam Kaeedi iD, Sanaz Heydari Havadaragh iD

Case Reports in Neurological Medicine · 2026-01 · 2026 (1)

DOI: 10.1155/crnm/1186165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Neurological Medicine, online erschienen am 26.05.2026. Verfasst von Mohammad Hossein Harirchian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients with multiple sclerosis (MS) are not immune to developing comorbid conditions, including malignant disorders. A new neurologic worsening in a known MS patient, despite being on immunosuppressive or even antineoplastic therapy, could be a malignant condition, other than MS relapse. Case Presentation We report a middle‐aged woman with a known history of MS and under treatment with rituximab from a few years ago, who subsequently developed clinical and imaging features that were not typical for MS relapse, which was pathologically confirmed to be a diffuse large B‐cell lymphoma (DLBCL).

Conclusion

It is important to consider the possibility of superimposed comorbid disorders, especially malignant conditions, in the setting of immunosuppressive therapy in MS patients. Considering red flags is an important task before the diagnosis of MS relapse as an explanation for new neurologic worsening.

Schlagwörter

Stichwörter der Autor:innen

comorbid conditionslymphomamultiple sclerosis

Autor:innen und Institutionen

  • Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.
  • Department of Neurology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran, skums.ac.ir.
  • Department of Pathology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.

ORCID-Profile: Mohammad Hossein Harirchian, Seyed Ehsan Mohammadianinejad, Asghar Bayati, Vahid Soleimani, Zahra Sarvestani, Maryam Kaeedi, Sanaz Heydari Havadaragh

Zitieren

APA

Harirchian, M. H., Mohammadianinejad, S. E., Bayati, A., Soleimani, V., Sarvestani, Z., Kaeedi, M., & Havadaragh, S. H. (2026). The Sanctuary Within: Development of CD20+ CNS Lymphoma Despite Peripheral B‐Cell Depletion by Rituximab in a Multiple Sclerosis Patient. Case Reports in Neurological Medicine, 2026(1). https://doi.org/10.1155/crnm/1186165

Vancouver

Harirchian MH, Mohammadianinejad SE, Bayati A, Soleimani V, Sarvestani Z, Kaeedi M, et al. The Sanctuary Within: Development of CD20+ CNS Lymphoma Despite Peripheral B‐Cell Depletion by Rituximab in a Multiple Sclerosis Patient. Case Reports in Neurological Medicine. 2026;2026(1). doi:10.1155/crnm/1186165

BibTeX
@article{Harirchian2026,
  author = {Harirchian, Mohammad Hossein and Mohammadianinejad, Seyed Ehsan and Bayati, Asghar and Soleimani, Vahid and Sarvestani, Zahra and Kaeedi, Maryam and Havadaragh, Sanaz Heydari},
  title = {The Sanctuary Within: Development of CD20+ CNS Lymphoma Despite Peripheral B‐Cell Depletion by Rituximab in a Multiple Sclerosis Patient},
  journal = {Case Reports in Neurological Medicine},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crnm/1186165}
}
Kostenlos starten →